naloxone and Eczema

naloxone has been researched along with Eczema* in 1 studies

Other Studies

1 other study(ies) available for naloxone and Eczema

ArticleYear
Life-threatening opioid toxicity from a fentanyl patch applied to eczematous skin.
    BMJ case reports, 2015, Apr-29, Volume: 2015

    A 19-year-old man with a history of eczema was admitted to the emergency department following collapsing at home. The paramedics found him unresponsive with poor respiratory effort and a widespread erythematous rash. Anaphylaxis, thought to be secondary to flucloxacillin he had recently been prescribed, was diagnosed. Epinephrine, steroids and antihistamines were administered without clinical improvement. On arrival to hospital, constricted pupils were noted prompting the emergency physicians to consider opiate toxicity. Intravenous naloxone brought about an immediate recovery. His father subsequently disclosed that he had given his son one of his own fentanyl patches to alleviate the distressing symptoms of eczema. Although the patient had removed the patch prior to collapsing, he had suffered life-threatening opioid toxicity likely due to enhanced opiate absorption through eczematous skin. This case highlights the risks associated with fentanyl patches in patients with chronic skin conditions.

    Topics: Administration, Cutaneous; Analgesics, Opioid; Eczema; Fentanyl; Humans; Male; Naloxone; Narcotic Antagonists; Self Medication; Transdermal Patch; Young Adult

2015